These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32727574)

  • 1. Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model.
    Rashid M; Sarfraz M; Arafat M; Hussain A; Abbas N; Sadiq MW; Rasool MF; Bukhari NI
    BMC Pharmacol Toxicol; 2020 Jul; 21(1):56. PubMed ID: 32727574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
    Yun YE; Edginton AN
    J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension.
    Hogg RJ; Delucchi A; Sakihara G; Wells TG; Tenney F; Batisky DL; Blumer JL; Vogt BA; Lo MW; Hand E; Panebianco D; Rippley R; Shaw W; Shahinfar S
    Pediatr Nephrol; 2007 May; 22(5):695-701. PubMed ID: 17216247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of pediatric dose of tirzepatide from the reference adult dose using physiologically based pharmacokinetic modelling.
    Guan R; Li X; Ma G
    Front Pharmacol; 2023; 14():1326373. PubMed ID: 38089044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
    Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
    Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of Physiologically Based Pharmacokinetic Model of Levetiracetam to Predict Exposure and Dose Optimization in Pediatrics.
    Shao W; Shen C; Wang W; Sun H; Wang X; Geng K; Wang X; Xie H
    J Pharm Sci; 2023 Oct; 112(10):2667-2675. PubMed ID: 37023853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic modelling of lisinopril in children: A case story of angiotensin converting enzyme inhibitors.
    Xie F; Van Bocxlaer J; Vermeulen A
    Br J Clin Pharmacol; 2021 Mar; 87(3):1203-1214. PubMed ID: 32693432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population.
    Maglalang PD; Sinha J; Zimmerman K; McCann S; Edginton A; Hornik CP; Hornik CD; Muller WJ; Al-Uzri A; Meyer M; Chen JY; Anand R; Perrin EM; Gonzalez D;
    Clin Pharmacokinet; 2024 Jun; 63(6):885-899. PubMed ID: 38814425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.
    Willmann S; Becker C; Burghaus R; Coboeken K; Edginton A; Lippert J; Siegmund HU; Thelen K; Mück W
    Clin Pharmacokinet; 2014 Jan; 53(1):89-102. PubMed ID: 23912563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically Based Pharmacokinetic Modeling to Supplement Nilotinib Pharmacokinetics and Confirm Dose Selection in Pediatric Patients.
    Heimbach T; Lin W; Hourcade-Potelleret F; Tian X; Combes FP; Horvath N; He H
    J Pharm Sci; 2019 Jun; 108(6):2191-2198. PubMed ID: 30721710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the combined preparation of lisinopril and hydrochlorothiazide on Chinese healthy volunteers.
    Wei Y; Sun YY; Wang KS; Sun DL; Zheng MY
    Yao Xue Xue Bao; 2011 Aug; 46(8):955-61. PubMed ID: 22007522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol.
    T'jollyn H; Vermeulen A; Van Bocxlaer J
    AAPS J; 2018 Nov; 21(1):8. PubMed ID: 30498862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age Groups.
    Liu XI; van den Anker JN; Burckart GJ; Dallmann A
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S94-S107. PubMed ID: 34185902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.
    Khalil F; Läer S
    AAPS J; 2014 Mar; 16(2):226-39. PubMed ID: 24399240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.
    Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F
    Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam.
    Maharaj AR; Barrett JS; Edginton AN
    AAPS J; 2013 Apr; 15(2):455-64. PubMed ID: 23344790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Pediatric Rectal Absorption, Drug Disposition, and Sedation Level for Midazolam Gel Using Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.
    Zhu J; Zhou S; Wang L; Zhao Y; Wang J; Zhao T; Li T; Shao F
    Mol Pharm; 2024 May; 21(5):2187-2197. PubMed ID: 38551309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
    Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I
    Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers.
    Gascón AR; Cuadrado A; Solinís MA; Hernández RM; Ramírez E; Dalmau R; Pedraz JL
    Int J Clin Pharmacol Ther; 2003 Jul; 41(7):309-15. PubMed ID: 12875347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.
    Hornik CP; Wu H; Edginton AN; Watt K; Cohen-Wolkowiez M; Gonzalez D
    Clin Pharmacokinet; 2017 Nov; 56(11):1343-1353. PubMed ID: 28290120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.